GRB7 (Growth factor receptor bound protein 7) is an adapter protein that mediates signal transduction from multiple cell surface receptors to downstream signaling pathways 1. The protein contains a conserved multidomain structure including an amino-terminal proline-rich region, a central GM region with a PH domain, and a carboxyl-terminal SH2 domain 1. GRB7 functions as a critical mediator of EGFR/ErbB signaling, interacting with phospho-tyrosine-related signaling molecules to regulate cell proliferation, migration, and differentiation 2. The protein promotes activation of downstream kinases including STAT3, AKT1, and MAPK pathways, and facilitates epithelial-mesenchymal transition through Notch1 and Wnt/β-catenin signaling 3. GRB7 expression is dysregulated across multiple cancer types, with overexpression associated with poor prognosis in HER2+ breast cancer and pancreatic adenocarcinoma, while downregulation occurs in kidney cancers 43. The protein's dimerization state appears regulated by tyrosine phosphorylation, with phosphorylation promoting monomeric forms that may affect RTK binding 5. Membrane localization of GRB7 may be associated with better prognosis in breast and ovarian cancers 6, highlighting its potential as both a diagnostic biomarker and therapeutic target.